Evaluation of the Hemostatic Effect of an Innovative Tissue Adhesive during Extraction Therapy under Rivaroxaban in a Rodent Model
Source abstract
Abstract
An increase in rivaroxaban therapies is associated with increased numbers of postoperative bleeding despite the use of hemostatic sponges, which are currently the gold standard treatment. VIVO has shown promising hemostatic results, favorable tissue properties, and ease of application, although it has not yet been used in the oral cavity. The aim of this study was to evaluate the hemostatic properties of VIVO in the extraction sockets of 31 rodents and compare this to gelatin sponge (GSP) therapy. At rivaroxaban concentrations of 264.10 ± 250.10 ng/mL, 62 extraction sockets were generated, of which 31 were treated with VIVO and 31 with GSP. The duration time, early and late bleeding events, and wound healing score were determined. Histologic examinations of the tissues were performed after 5 days. VIVO presented a longer procedure, 1.26 ± 0.06 min, but a significantly shorter bleeding time, 0.14 ± 0.03 min. There was no difference between the two groups in terms of the severity and timing of bleeding. More minor early bleeding events were observed for GSP. VIVO showed a significantly better healing score, with favorable histological results. In an animal study, VIVO showed promising hemostatic properties after tooth extraction under ongoing anticoagulative therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hemostasis and retained surgical items · Surgical Sutures and Adhesives · Blood Coagulation and Thrombosis Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oral and Cranio-Maxillofacial Surgery, University Hospital RWTH Aachen, Pauwelstraße 30, 52074 Aachen, Germany
Clinic for Anesthesiology/Operative Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelstraße 30, 52074 Aachen, Germany
Funding
Faculty of Medicine of the Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University
References (48)
Show source-provided references
1. Boccatonda, A., Frisone, A., Lorusso, F., Bugea, C., Di Carmine, M., Schiavone, C., Cocco, G., D’Ardes, D., Scarano, A., and Guagnano, M.T. (2023). Perioperative Management of Antithrombotic Therapy in Patients Who Undergo Dental Procedures: A Systematic Review of the Literature and Network Meta-Analysis. Int. J. Environ. Res. Public Health, 20.10.3390/ijerph20075293 ↗
2. Documentation of various approaches and outcomes in patients on warfarin undergoing dental procedures: A review article
3. Chaushu, L.P.N., Botticelli, D., Porfirio Xavier, S., Kolerman, R., and Masri, D. (2023). The Effect of Anticoagulants on Early Implant Failure: A Retrospective Cohort Study. J. Funct. Biomater., 14.10.3390/jfb14040186 ↗
4. Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: A prospective case-control study10.1007/s00784-016-2010-1 ↗
5. Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting10.1634/theoncologist.2017-0473 ↗
6. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation10.1016/j.jacc.2017.03.540 ↗
7. Antidotes for the direct oral anticoagulants: What news?10.1016/j.thromres.2018.01.006 ↗
8. Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: A Narrative Review10.1007/s12325-022-02333-9 ↗
9. Testing and monitoring direct oral anticoagulants10.1182/blood-2018-04-791541 ↗
10. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants10.1093/ehjcvp/pvw031 ↗
11. Novel oral anticoagulants and exodontia: The evidence10.1038/sj.bdj.2017.364 ↗
12. Postoperative bleeding after dental extraction among elderly patients under anticoagulant therapy10.1007/s00784-020-03559-z ↗
13. Is L-PRF an effective hemostatic agent in single tooth extractions? A cohort study on VKA and DOAC patients10.1007/s00784-023-04880-z ↗
14. Galletti, G., Alfonsi, F., Raffaele, A., Valente, N.A., Chatelain, S., Kolerman, R., Cinquini, C., Romeggio, S., Iezzi, G., and Barone, A. (2020). Implant Placement in Patients under Treatment with Rivaroxaban: A Retrospective Clinical Study. Int. J. Environ. Res. Public Health, 17.10.3390/ijerph17124607 ↗
15. Manfredini, M., Poli, P.P., Creminelli, L., Porro, A., Maiorana, C., and Beretta, M. (2021). Comparative Risk of Bleeding of Anticoagulant Therapy with Vitamin K Antagonists (VKAs) and with Non-Vitamin K Antagonists in Patients Undergoing Dental Surgery. J. Clin. Med., 10.10.3390/jcm10235526 ↗
16. The effectiveness of a new method using an extra-alveolar hemostatic agent after dental extractions in older patients on oral anticoagulation treatment: An intrapatient study10.1016/j.oooo.2015.02.482 ↗
17. Interventions for treating post-extraction bleeding
18. Current thoughts on treatment of patients receiving anticoagulation therapy10.1016/j.joms.2010.04.007 ↗
19. Haemostasis in oral surgical procedures involving patients with a ventricular assist device10.1016/j.ijom.2019.07.009 ↗
20. Evaluation of the long-term results of vascular anastomosis using polyurethane adhesive and shape-memory stent in the rat carotid artery model10.1002/micr.30926 ↗
21. Hemostatic Efficacy and Safety of the Novel Medical Adhesive, MAR VIVO-107, in a Rabbit Liver Resection Model10.1159/000481818 ↗
22. A polyurethane-based surgical adhesive for sealing blood vessel anastomoses-A feasibility study in pigs10.1002/jbm.b.35049 ↗
23. Bremer, L., Hagemeister, K., Moss, M., Ernst, L., Tolba, R.H., Jockenhoevel, S., and Apel, C. (2023). Long-Term Degradation Assessment of a Polyurethane-Based Surgical Adhesive-Assessment and Critical Consideration of Preclinical In Vitro and In Vivo Testing. J. Funct. Biomater., 14.10.3390/jfb14030168 ↗
24. Biodegradation and Immunological Parameters of Polyurethane-Based Tissue Adhesive in Arterial Microvascular Anastomoses-A Long-Term In Vivo Study10.1002/mabi.202100451 ↗
25. Tranexamic acid to reduce bleeding after dental extraction in patients treated with non-vitamin K oral anticoagulants: Design and rationale of the EXTRACT-NOAC trial10.1016/j.bjoms.2019.10.297 ↗
26. Evaluation of early wound healing scales/indexes in oral surgery: A literature review10.1111/cid.12680 ↗
27. An assessment of clinical wound evaluation scales10.1111/j.1553-2712.1998.tb02465.x ↗
28. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences10.3758/BF03193146 ↗
29. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses10.3758/BRM.41.4.1149 ↗
30. Dental implant surgery in patients in treatment with the anticoagulant oral rivaroxaban10.1111/clr.12653 ↗
31. Hiroshi, I., Natsuko, S.Y., Yutaka, I., Masayori, S., Hiroyuki, N., and Hirohisa, I. (2022). Frequency of hemorrhage after tooth extraction in patients treated with a direct oral anticoagulant: A multicenter cross-sectional study. PLoS ONE, 17.10.1371/journal.pone.0266011 ↗
32. Risk factors for bleeding after dental extractions in patients receiving antithrombotic drugs—A case control study10.1016/j.jds.2021.10.005 ↗
33. Yan, W., Yang, F., Liu, Z., Wen, Q., Gao, Y., Niu, X., and Zhao, Y. (2022). Anti-Inflammatory and Mineralization Effects of an ASP/PLGA-ASP/ACP/PLLA-PLGA Composite Membrane as a Dental Pulp Capping Agent. J. Funct. Biomater., 13.10.3390/jfb13030106 ↗
34. Edanami, N., Takenaka, S., Ibn Belal, R.S., Yoshiba, K., Takahara, S., Yoshiba, N., Ohkura, N., and Noiri, Y. (2023). In Vivo Assessment of the Apatite-Forming Ability of New-Generation Hydraulic Calcium Silicate Cements Using a Rat Subcutaneous Implantation Model. J. Funct. Biomater., 14.10.21203/rs.3.rs-2030069/v2 ↗
35. Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosis10.1097/MBC.0b013e32834cb30e ↗
36. Polyphosphate-crosslinked collagen scaffolds for hemostasis and alveolar bone regeneration after tooth extraction10.1016/j.bioactmat.2021.12.019 ↗
37. Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model10.1038/s41598-018-25820-y ↗
38. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans10.1124/dmd.108.025569 ↗
39. Direct Rivaroxaban-Induced Factor XA Inhibition Proves to be Cardioprotective in Rats10.1097/SHK.0000000000001412 ↗
40. Safety of tooth extraction in patients receiving direct oral anticoagulant treatment versus warfarin: A prospective observation study10.1016/j.ijom.2019.01.013 ↗
41. Risk factors for postoperative complications following oral surgery10.1590/1678-775720150130 ↗
42. Rivaroxaban for treatment of livedoid vasculopathy: A systematic review10.1111/dth.15051 ↗
43. Rivaroxaban in the treatment of upper extremity deep vein thrombosis: A single-center experience and review of the literature10.1016/j.thromres.2019.07.008 ↗
44. Host inflammatory response and clinical parameters around implants in a rat model using systemic alendronate and zoledronate acid drug administrations10.1038/s41598-022-08308-8 ↗
45. Haemostatic agents in apical surgery. A systematic review
46. Prevention of post-operative bleeding in hemostatic compromised patients using native porcine collagen fleeces-retrospective study of a consecutive case series10.1007/s10006-016-0560-7 ↗
47. Intraoperative anaphylaxis to gelatin-based hemostatic agents: A case report10.2147/JAA.S202784 ↗
48. Mechanical strength and hydrostatic testing of VIVO adhesive in sutureless microsurgical anastomoses: An ex vivo study10.1038/s41598-021-92998-z ↗